Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Intangibles: 2024

Historic Intangibles for Madrigal Pharmaceuticals (MDGL) over the last 1 years, with Dec 2024 value amounting to $4.7 million.

  • Madrigal Pharmaceuticals' Intangibles rose 55.16% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 55.16%. This contributed to the annual value of $4.7 million for FY2024, which is N/A change from last year.
  • As of FY2024, Madrigal Pharmaceuticals' Intangibles stood at $4.7 million.
  • Madrigal Pharmaceuticals' 5-year Intangibles high stood at $4.7 million for FY2024, and its period low was $4.7 million during FY2024.
  • Moreover, its 1-year median value for Intangibles was $4.7 million (2024), whereas its average is $4.7 million.